The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1250 articles
New research shows that GLP-1 receptor agonists may significantly reduce asthma exacerbations and the need for steroids in obese patients with asthma. This opens up promising new avenues in metabolic health and asthma management.
Eli Lilly's Zepbound is now available at Walmart pharmacies, making it easier for individuals to access this GLP-1 medication. This expansion offers a convenient option for those seeking weight loss support and managing their metabolic health.
New data reveals a drop in obesity rates alongside increased use of GLP-1 weight-loss drugs. This blog explores the connection, offers actionable insights, and discusses the implications for your health and wellness journey.
GLP-1 drugs are revolutionizing weight loss globally. This post explores the impact of these medications, their potential benefits beyond weight loss, and how to monitor your health on this journey.
Recent studies shed light on the impact of GLP-1 medications like Ozempic and Wegovy on weight loss and heart health. Learn about the latest findings, including the role of testosterone, and discover actionable tips for improving your metabolic health.
New research highlights the critical role of the gut-brain-immune axis in neurodegenerative diseases. Understanding this connection could unlock new approaches for prevention and treatment. Read on for key insights!
This post explores the risks associated with black market weight loss injections, emphasizing the importance of safety and informed healthcare choices. Understanding the potential dangers of unregulated treatments, such as semaglutide, is crucial for your well-being.
The Welsh NHS is pausing prescriptions for weight loss drugs due to overwhelming demand. This blog explores the situation, discusses the impact on those seeking treatment, and offers insights on how to focus on overall health and well-being.
New research shows that Mazdutide may be superior to Semaglutide (Ozempic/Wegovy) for weight loss and improved blood sugar control. Learn about this exciting development and what it means for the future of diabetes and weight management.
